Introduction

We're interested in the expandability of collaborative research and new models of how discovery happens. Our research series started with one patient, their genomic data and 150 researchers and engineers with the desire to create a greater body of knowledge forward for a rare neuro-cancer. Our first research collaboration showed incredible results and a promise for how short bursts of research could be useful and integrated into industry and academia.

Purpose

  • Advance research for rare and undiagnosed disease.
  • Contribute to real, ongoing patient cases.
  • Create interdisciplinary networks of computer scientists and biologists.
  • Learn and develop skills in AI/ML, computational biology and cancer genomics.
  • Build an open community for collaborative biomedicine discovery.

FOCUS AREAS

Neurofibromatosis Type 2 (NF2)

Papillary Renal-Cell Carcinoma Type 1 (p1RCC)

Data

We work with genome sequencing partners to produce novel, open datasets for our research community. We also take advantage of public resources like the NIH's Cancer Genome Atlas to supplement our research efforts. 

Partners

We're interested in partnering with technology, genomics and medical organizations across the non-profit, foundation, startup and large enterprise spectrum. Please get in touch to learn more about partnership opportunities.

Patient Communities

We are actively working on researching and selecting our next areas of focus. We partner with patients and patient communities as the foundation of our research collaborations. If you are connected to a patient community and would like to help organize more research for that disease category, please get in touch with us!

AI/ML Engineers & Biomedicine Researchers

Our research events will occur approximately on a quarterly basis. Please join our mailing list to be the first to hear when the next one is live! In addition to SF, we are working to expand our research series outside of the Bay Area this year.